TFBS Bioscience Inc. (6939.TWO)

TWD 32.3

(1.1%)

Total Liabilities Summary of TFBS Bioscience Inc.

  • TFBS Bioscience Inc.'s latest annual total liabilities in 2023 was 187.43 Million TWD , up 48.54% from previous year.
  • TFBS Bioscience Inc.'s latest quarterly total liabilities in 2023 FY was 187.43 Million TWD , up 48.54% from previous quarter.
  • TFBS Bioscience Inc. reported annual total liabilities of 126.18 Million TWD in 2022, up 89.94% from previous year.
  • TFBS Bioscience Inc. reported annual total liabilities of 66.43 Million TWD in 2021, up 64.41% from previous year.
  • TFBS Bioscience Inc. reported quarterly total liabilities of 187.43 Million TWD for 2023 Q4, up 99.52% from previous quarter.
  • TFBS Bioscience Inc. reported quarterly total liabilities of 93.94 Million TWD for 2023 Q2, down -25.55% from previous quarter.

Annual Total Liabilities Chart of TFBS Bioscience Inc. (2023 - 2020)

Historical Annual Total Liabilities of TFBS Bioscience Inc. (2023 - 2020)

Year Total Liabilities Total Liabilities Growth
2023 187.43 Million TWD 48.54%
2022 126.18 Million TWD 89.94%
2021 66.43 Million TWD 64.41%
2020 40.4 Million TWD 0.0%

Peer Total Liabilities Comparison of TFBS Bioscience Inc.

Name Total Liabilities Total Liabilities Difference
BIONET Corp. 626.46 Million TWD 70.08%
DIVA Laboratories, Ltd. 210.93 Million TWD 11.139%
Genetics Generation Advancement Corp. 164.9 Million TWD -13.662%
Welgene Biotech Co.,Ltd. 247.89 Million TWD 24.389%
Puriblood Medical Co., Ltd. 84.35 Million TWD -122.21%